Tirzepatide, sold as Mounjaro and Zepbound, activated calorie-burning brown fat in obese mice, revealing a potential metabolic effect beyond appetite suppression. If confirmed in humans, the finding could help explain the drug’s powerful benefits and inspire more comprehensive treatments for obesity and diabetes.
Source: https://www.sciencedaily.com/releases/2 ... 093210.htm
Source: https://www.sciencedaily.com/releases/2 ... 093210.htm
